WallStreetZenWallStreetZen

NASDAQ: WHWK
Whitehawk Therapeutics Inc Stock Ownership - Who owns Whitehawk Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Whitehawk Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Baiteng ZhaoDirector2025-03-041,250,000$2.40
$3.00MBuy
Bryan BallChief Technical Operations Officer and SVP Manufacturing Operations2025-03-04100,000$2.40
$240.00kBuy
Caley CasteleinDirector2025-03-041,666,000$2.40
$4.00MBuy
Anupam DalalDirector2025-03-041,561,000$2.40
$3.75MBuy
Bryan BallChief Technical Operations Officer and SVP Manufacturing Operations2025-03-032,147$2.35
$5.05kSell
Scott M. GiacobelloCHIEF FINANCIAL OFFICER2025-03-032,806$2.35
$6.59kSell
David James LennonCHIEF EXECUTIVE OFFICER2025-03-035,690$2.35
$13.37kSell
David James LennonCHIEF EXECUTIVE OFFICER2024-10-039,689$1.94
$18.80kSell
Neil DesaiEXECUTIVE CHAIRMAN2024-09-0340,000$1.71
$68.32kSell
Neil DesaiEXECUTIVE CHAIRMAN2024-08-055,652$1.34
$7.60kSell

1 of 2

WHWK insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when WHWK insiders and whales buy or sell their stock.

WHWK Shareholders

What type of owners hold Whitehawk Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Muneer A. Satter12.02%5,621,835$8.26MInsider
Orbimed Advisors LLC11.10%5,193,946$7.64MInsider
Chau Quang Khuong11.10%5,193,946$7.64MInsider
Novartis Bioventures Ltd8.66%4,049,804$5.95MInsider
Behzad Aghazadeh7.42%3,471,752$5.10MInsider
Anupam Dalal7.29%3,411,532$5.01MInsider
Caley Castelein7.26%3,397,100$4.99MInsider
Avoro Capital Advisors LLC6.09%2,849,402$4.19MInstitution
Qvt Financial LP4.95%2,313,702$3.40MInstitution
Bml Capital Management LLC4.49%2,100,000$3.09MInstitution

1 of 3

WHWK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
WHWK27.58%72.42%Net BuyingNet Buying
MAIA4.68%16.62%Net BuyingNet Buying
ABOS70.15%17.11%Net Selling
BYSI13.07%2.02%
ADVM31.00%69.00%Net BuyingNet Buying
View Top Biotech Stocks

Whitehawk Therapeutics Stock Ownership FAQ

Who owns Whitehawk Therapeutics?

Whitehawk Therapeutics (NASDAQ: WHWK) is owned by 31.98% institutional shareholders, 83.97% Whitehawk Therapeutics insiders, and 0.00% retail investors. Muneer A. Satter is the largest individual Whitehawk Therapeutics shareholder, owning 5.62M shares representing 12.02% of the company. Muneer A. Satter's Whitehawk Therapeutics shares are currently valued at $8.32M.

If you're new to stock investing, here's how to buy Whitehawk Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.